Schuetz Thomas J. 4
4 · Compass Therapeutics, Inc. · Filed Nov 21, 2023
Insider Transaction Report
Form 4
Schuetz Thomas J.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Tax Payment
Common Stock
2023-11-17$1.50/sh−44,025$66,038→ 5,977,848 total
Footnotes (2)
- [F1]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs").
- [F2]12,222 of these shares of common stock underlie unvested restricted stock awards that are subject to a right of repurchase in favor of the issuer, which will vest on November 30 and December 31, 2023. 300,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on November 16, 2021. 500,000 of the shares represents unvested restricted stock units ("RSU") granted to the reporting person on February 8, 2023. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on November 15, 2022.